Featured Research

from universities, journals, and other organizations

School-based program reduces risky sexual behaviors in South African teens

Date:
October 4, 2010
Source:
JAMA and Archives Journals
Summary:
A school-based, six-session program targeting sexual risk behaviors appeared to reduce rates of unprotected sex and sex with multiple partners among South African sixth-graders, according to a new report.

A school-based, six-session program targeting sexual risk behaviors appeared to reduce rates of unprotected sex and sex with multiple partners among South African sixth-graders, according to a report in the October issue of Archives of Pediatrics & Adolescent Medicine.

South Africa has an estimated 5.5 million individuals living with HIV or another sexually transmitted disease (STD), more than any other nation in the world, according to background information in the article. Almost 20 percent of South Africans age 15 to 49 have HIV, with new infections most common among those age 15 to 24. "It is estimated that more than one-half of all South African individuals aged 15 years in 2006 will not survive to 60 years of age," the authors write. "Young adolescents, before or just after the initiation of sexual activity, are singularly important to intervention efforts because they are highly vulnerable and have not established habitual patterns of sexual behavior."

To test the efficacy of a school-based prevention program in this environment, John B. Jemmott III, Ph.D., of the University of Pennsylvania, Philadelphia, and colleagues conducted a cluster-randomized, controlled study involving 18 primary schools in Eastern Cape Providence, South Africa and two six-session behavior-change interventions based on extensive research.

Nine schools were randomly assigned to participate in the HIV/STD intervention, which was designed to teach students how to avoid HIV and other STDs, enhance beliefs supporting abstinence and condom use, and increase the skills and self-confidence needed to choose less risky behaviors. The health-promotion intervention focused on behaviors linked to other diseases, such as heart disease, diabetes and cancer. The 1,057 participating children (average age 12.4) were asked about sexual behaviors before and three, six and 12 months after the intervention.

Averaged over the three follow-ups, a significantly smaller percentage of students in the HIV/STD risk reduction group than the health promotion group reported having unprotected vaginal intercourse (2.2 percent vs. 4.2 percent), having vaginal intercourse at all (4.8 percent vs. 7.2 percent) or having multiple sexual partners (1.8 percent vs. 3.2 percent).

"In conclusion, sexual transmission of HIV is a major risk faced by adolescents in sub-Saharan Africa, and interventions are needed urgently to reduce their risk," the authors write. "This study provides the first evidence that a theory-based, contextually appropriate intervention can reduce sexual risk behaviors, particularly unprotected vaginal intercourse, vaginal intercourse and multiple partners, among young South African adolescents in the earliest stages of their sexual lives."

"Future research with more sexually experienced adolescents will have to explore whether such interventions can have an effect on condom use and STDs, including HIV."

This study was funded by a research grant from the National Institute of Mental Health.



Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. B. Jemmott, L. S. Jemmott, A. O'Leary, Z. Ngwane, L. D. Icard, S. L. Bellamy, S. F. Jones, J. R. Landis, G. A. Heeren, J. C. Tyler, M. B. Makiwane. School-Based Randomized Controlled Trial of an HIV/STD Risk-Reduction Intervention for South African Adolescents. Archives of Pediatrics and Adolescent Medicine, 2010; 164 (10): 923 DOI: 10.1001/archpediatrics.2010.176

Cite This Page:

JAMA and Archives Journals. "School-based program reduces risky sexual behaviors in South African teens." ScienceDaily. ScienceDaily, 4 October 2010. <www.sciencedaily.com/releases/2010/10/101004162926.htm>.
JAMA and Archives Journals. (2010, October 4). School-based program reduces risky sexual behaviors in South African teens. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/10/101004162926.htm
JAMA and Archives Journals. "School-based program reduces risky sexual behaviors in South African teens." ScienceDaily. www.sciencedaily.com/releases/2010/10/101004162926.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins